Clinical Trial Update: A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel [Phase 2]

View source ↗

Summary

Phase 2 multicenter randomized trial evaluating CNTF for Macular Telangiectasia Type 2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Telangiectasia Type

Drugs mentioned

• CNTF (Ciliary Neurotrophic Factor)

Snippet

Sponsor: Neurotech Pharmaceuticals | Conditions: Macular Telangiectasia Type 2 | Phase 2 | Status: COMPLETED